Venture
Affiliations
State University of New York Downstate
Technologies
Therapeutic
Indication
Basic Research
Cardiovascular Disease
Clinical Trials
Education
Nephrology
Oncology
Orphan Diseases
Women’s health
Website
vasocuretherapeutics.comVasocure is a preclinical-stage vascular therapeutics company with the world’s first peptide to directly treat neointimal disease and atherosclerosis.
Vasocure Team:
Eugene Dinescu